Divi's Laboratories Limited (DIVISLAB.BO)
INR 5592.9
(3.89%)
INR 5592.9
(3.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 32.44 Billion INR | -29.67% |
| 2022 | 46.12 Billion INR | -20.92% |
| 2021 | 58.32 Billion INR | 28.62% |
| 2020 | 45.34 Billion INR | 42.47% |
| 2019 | 31.82 Billion INR | 6.85% |
| 2018 | 29.78 Billion INR | 31.02% |
| 2017 | 22.73 Billion INR | -9.76% |
| 2016 | 25.19 Billion INR | 11.23% |
| 2015 | 22.64 Billion INR | 19.1% |
| 2014 | 19.01 Billion INR | 17.54% |
| 2013 | 16.17 Billion INR | 20.19% |
| 2012 | 13.46 Billion INR | 22.14% |
| 2011 | 11.02 Billion INR | 54.55% |
| 2010 | 7.13 Billion INR | 30.85% |
| 2009 | 5.45 Billion INR | -1.92% |
| 2008 | 5.55 Billion INR | -94.34% |
| 2007 | 98.17 Billion INR | 2645.58% |
| 2006 | 3.57 Billion INR | 100.74% |
| 2005 | 1.78 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 8.76 Billion INR | -13.18% |
| 2023 Q3 | 11.26 Billion INR | 2.46% |
| 2023 FY | 32.44 Billion INR | -29.67% |
| 2023 Q2 | 10.99 Billion INR | 0.83% |
| 2023 Q1 | 10.9 Billion INR | 6.69% |
| 2023 Q4 | 10.09 Billion INR | -10.39% |
| 2022 Q3 | 9.68 Billion INR | -17.96% |
| 2022 FY | 46.12 Billion INR | -20.92% |
| 2022 Q1 | 14.43 Billion INR | -5.02% |
| 2022 Q2 | 11.8 Billion INR | -18.23% |
| 2022 Q4 | 10.21 Billion INR | 5.53% |
| 2021 Q2 | 13.32 Billion INR | 1.08% |
| 2021 Q3 | 16.61 Billion INR | 24.69% |
| 2021 Q4 | 15.19 Billion INR | -8.57% |
| 2021 FY | 58.32 Billion INR | 28.62% |
| 2021 Q1 | 13.18 Billion INR | 20.33% |
| 2020 FY | 45.34 Billion INR | 42.47% |
| 2020 Q4 | 10.95 Billion INR | -6.73% |
| 2020 Q3 | 11.74 Billion INR | 0.15% |
| 2020 Q2 | 11.73 Billion INR | 7.56% |
| 2020 Q1 | 10.9 Billion INR | 41.45% |
| 2019 FY | 31.82 Billion INR | 6.85% |
| 2019 Q3 | 8.49 Billion INR | -0.33% |
| 2019 Q2 | 8.51 Billion INR | 19.89% |
| 2019 Q4 | 7.71 Billion INR | -9.19% |
| 2019 Q1 | 7.1 Billion INR | 12.02% |
| 2018 Q1 | 6.26 Billion INR | 0.0% |
| 2018 FY | 29.78 Billion INR | 31.02% |
| 2018 Q4 | 6.34 Billion INR | -28.43% |
| 2018 Q3 | 8.86 Billion INR | 6.55% |
| 2018 Q2 | 8.31 Billion INR | 32.78% |
| 2017 FY | 22.73 Billion INR | -9.76% |
| 2016 FY | 25.19 Billion INR | 11.23% |
| 2015 FY | 22.64 Billion INR | 19.1% |
| 2014 Q4 | 5.25 Billion INR | 0.0% |
| 2014 FY | 19.01 Billion INR | 17.54% |
| 2013 Q4 | 4.4 Billion INR | 0.0% |
| 2013 FY | 16.17 Billion INR | 20.19% |
| 2012 Q4 | 3.97 Billion INR | 0.0% |
| 2012 FY | 13.46 Billion INR | 22.14% |
| 2011 FY | 11.02 Billion INR | 54.55% |
| 2010 FY | 7.13 Billion INR | 30.85% |
| 2009 FY | 5.45 Billion INR | -1.92% |
| 2008 FY | 5.55 Billion INR | -94.34% |
| 2007 FY | 98.17 Billion INR | 2645.58% |
| 2006 FY | 3.57 Billion INR | 100.74% |
| 2005 FY | 1.78 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 87.45% |
| NATCO Pharma Limited | 25.73 Billion INR | -26.049% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -686.753% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -3342.279% |
| Achyut Healthcare Limited | 4.86 Million INR | -667252.397% |
| Ajanta Pharma Limited | 21.06 Billion INR | -54.007% |
| Alkem Laboratories Limited | 52.29 Billion INR | 37.97% |
| Alpa Laboratories Limited | 188.89 Million INR | -17073.562% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -21.132% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -421.317% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 79.028% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -2104.095% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -777.84% |
| Brooks Laboratories Limited | 65.62 Million INR | -49336.148% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 80.172% |
| Eris Lifesciences Limited | 10.42 Billion INR | -211.122% |
| FDC Limited | 8.33 Billion INR | -289.214% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 53.216% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -160.919% |
| Granules India Limited | 16.79 Billion INR | -93.104% |
| Gufic Biosciences Limited | 4.16 Billion INR | -678.366% |
| Hester Biosciences Limited | 1.27 Billion INR | -2447.011% |
| Indoco Remedies Limited | 6.04 Billion INR | -436.969% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -423.702% |
| Ipca Laboratories Limited | 29.8 Billion INR | -8.823% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -4870.962% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -16732.099% |
| Lasa Supergenerics Limited | 121.02 Million INR | -26703.272% |
| Laurus Labs Limited | 24.62 Billion INR | -31.762% |
| Lupin Limited | 123.71 Billion INR | 73.779% |
| Mankind Pharma Limited | 44.52 Billion INR | 27.135% |
| Medicamen Biotech Limited | 495.49 Million INR | -6446.988% |
| Medico Remedies Limited | 262.14 Million INR | -12274.878% |
| Megasoft Limited | 342.07 Million INR | -9383.411% |
| Piramal Pharma Limited | 24.47 Billion INR | -32.566% |
| RPG Life Sciences Limited | 2.48 Billion INR | -1206.484% |
| Sigachi Industries Limited | 2 Billion INR | -1520.151% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 5485.073% |
| Unichem Laboratories Limited | 4.86 Billion INR | -566.813% |
| Wanbury Limited | 1.73 Billion INR | -1774.448% |
| Windlas Biotech Limited | 1.33 Billion INR | -2323.065% |
| ZIM Laboratories Limited | 1.26 Billion INR | -2460.607% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 74.092% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -461.11% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1984.12% |
| Bal Pharma Limited | 770.19 Million INR | -4111.92% |
| Strides Pharma Science Limited | 14.38 Billion INR | -125.464% |
| Venus Remedies Limited | 2.18 Billion INR | -1386.311% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -456.303% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -991.499% |
| Shilpa Medicare Limited | 3.54 Billion INR | -814.612% |
| Aarti Drugs Limited | 8.31 Billion INR | -290.082% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -608.173% |
| Suven Life Sciences Limited | -200.79 Million INR | 16255.62% |
| Ind-Swift Limited | 2.17 Billion INR | -1393.189% |
| Valiant Laboratories Limited | -60.66 Million INR | 53574.878% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -42.908% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -3666.837% |
| Themis Medicare Limited | 1.5 Billion INR | -2057.053% |
| Hikal Limited | 3.14 Billion INR | -932.109% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 30.62% |
| Sequent Scientific Limited | 2.97 Billion INR | -989.055% |
| Novartis India Limited | 1.32 Billion INR | -2344.796% |
| Wockhardt Limited | 16.24 Billion INR | -99.754% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -65.148% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -222401.149% |
| Neuland Laboratories Limited | 8.24 Billion INR | -293.315% |
| Morepen Laboratories Limited | 6.16 Billion INR | -426.514% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -5128.236% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -4510.541% |